| 1 |
Reed et al [19] |
The Detection of Monkeypox in Humans in the Western Hemisphere |
2004 |
New England Journal of Medicine |
449 |
Article |
| 2 |
Rogers et al [66] |
A preliminary assessment of silver nanoparticle inhibition of monkeypox virus plaque formation |
2008 |
Nanoscale Research Letters |
330 |
Article |
| 3 |
Earl et al [67] |
Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox |
2004 |
Nature |
292 |
Article |
| 4 |
Rimoin et al [12] |
Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo |
2010 |
Proceedings of the National Academy of Sciences of the United States of America |
291 |
Article |
| 5 |
Di Giulio and Eckburg [68] |
Human monkeypox: An emerging zoonosis |
2004 |
Lancet Infectious Diseases |
277 |
Review |
| 6 |
Bunge et al [15] |
The changing epidemiology of human monkeypox—A potential threat? A systematic review |
2022 |
PLOS Neglected Tropical Diseases |
261 |
Review |
| 7 |
Hutin et al [69] |
Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. |
2001 |
Emerging Infectious Diseases |
259 |
Article |
| 8 |
Likos et al [70] |
A tale of two clades: Monkeypox viruses |
2005 |
Journal of General Virology |
248 |
Article |
| 9 |
Edghill- Smith et al [71] |
Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus |
2005 |
Nature Medicine |
223 |
Article |
| 10 |
Adler et al [45] |
Clinical features and management of human monkeypox: a retrospective observational study in the UK |
2022 |
The Lancet Infectious Diseases |
209 |
Article |
